NCT01101984

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

A Randomized, Parallel- Group Comparison Study of DE-089 Ophthalmic Solution in Patients With Dry Eye (Comparison With 0.1% Sodium Hyaluronate Ophthalmic Solution) - A Multinational Study -

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: Santen Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 21 Years – 69 Years
• Healthy volunteers: Not accepted

Summary

Safety and efficacy of DE-089 ophthalmic solution in patients with dry eye will be evaluated in comparison with sodium hyaluronate ophthalmic solution.

Conditions

• Dry Eye

Interventions

Type	Name	Description
DRUG	diquafosol ophthalmic solution	DE-089 topical ocular application, 6 times daily for 4 weeks.
DRUG	0.1% sodium hyaluronate ophthalmic solution.	0.1% HA topical ocular application, 6 times daily for 4 weeks.

Timeline

• Start date: 2010-02-01
• Completion: 2012-04-01
• First posted: 2010-04-12
• Last updated: 2012-11-14

Locations

2 sites across 2 countries: China, Singapore